COVID Treatment Options

The FDA has issued emergency use authorization (EUA) for Molnupiravir and Paxlovid for the treatment of mild-to-moderate COVID-19.

Having new drugs that help reduce COVID hospitalizations and deaths is obviously wonderful news, but in no way is it a substitute for getting vaccinated. Preventing illness in the first place is always better than getting sick and then getting treated.

Dr. David Priest, Novant Health's chief safety, quality and epidemiology officer, explains in this article.

Sotrovimab (infusion)

Fact Sheet for Caregivers and Patients
Fact Sheet for Healthcare Providers

Molnupiravir

Paxlovid

FDA Emergency Use Authorization Letter
FDA Emergency Use Authorization Announcement
Fact Sheet for Healthcare Providers
Fact Sheet for Caregivers and Patients
Paxlovid effectiveness (British Medical Journal)

For Providers

Overview of Outpatient Therapies (from PHE)

Supplies of these medications are limited. Physicians can access the PDF below daily to check supplies at New Hanover Regional Medical Center.

COVID-19 Treatment Inventory

Molnupiravir Paper Order Form

Paxlovid Paper Order Form